State’s Stem Cell Agency Awards $18.2 Million Grant for B Cell Cancer Clinical Trial – UC San Diego Health
UC San Diego Health |
State’s Stem Cell Agency Awards $18.2 Million Grant for B Cell Cancer Clinical Trial
UC San Diego Health The Independent Citizens Oversight Committee of the California Institute for Regenerative Medicine (CIRM) today unanimously approved an $18.29 million grant to University of California San Diego School of Medicine researchers to fund a phase Ib/IIa … |
|
Global Cancer Gene Therapy Market 2017-2022: Expansion in Pharmaceutical Landscape & Growing Demand for …
Medgadget (blog) “Global Cancer Gene Therapy Market Professional Survey Report 2017-2022” Purchase This Report by calling ResearchnReports.com at +1-888-631-6977. Cancer Gene Therapy is the essential gene and cellular therapy resource for cancer researchers and … |
EurekAlert (press release) |
State’s stem cell agency awards $18.2 million grant for B cell cancer clinical trial
EurekAlert (press release) Kipps noted, too that cirmtuzumab targets cancer stem cells, which behave somewhat like the roots of the disease, resisting many forms of treatment and allowing a malignancy to grow back after apparently successful therapy. By targeting cancer stem … |
Futurism |
CRISPR May One Day Cure Sickle-Cell Disease
Futurism Sickle-cell disease, which afflicts approximately 100,000 Americans with immense pain and shortened life-span, is caused by a single mutated nucleotide within the gene that codes for hemoglobin, making it a top candidate for CRISPR — and maybe a cure. |